Legal Representation
Attorney
Michael W. Piper
USPTO Deadlines
Next Deadline
1437 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-06-20)
Due Date
June 20, 2029
Grace Period Ends
December 20, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
23 events| Date | Code | Type | Description |
|---|---|---|---|
| Oct 16, 2023 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Sep 26, 2023 | FIMP | P | FINAL DISPOSITION PROCESSED |
| Sep 26, 2023 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| Sep 20, 2023 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Jun 20, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Jun 20, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Apr 4, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Apr 4, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Mar 15, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Mar 2, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 17, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Feb 9, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Feb 9, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 9, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Oct 3, 2022 | RFNP | P | REFUSAL PROCESSED BY IB |
| Sep 10, 2022 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Sep 9, 2022 | RFRR | P | REFUSAL PROCESSED BY MPU |
| Aug 19, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Aug 18, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Aug 16, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Jun 28, 2022 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Jun 24, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jun 23, 2022 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 005
Vaccines; medicines for human purpose, namely pharmaceutical preparations for the treatment of genetic and immune system diseases and disorders, cancer, ophthalmic diseases and conditions, infectious diseases; biological preparations, namely pharmaceutical preparations for the treatment of genetic and immune system diseases and disorders, cancer, ophthalmic diseases and conditions, infectious diseases; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; dietetic beverages and foods adapted for medical use; medical diagnostic reagents; blood products, namely blood for medical purposes
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
USPTO Documents
Loading USPTO documents...